Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

409
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
409
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

706
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
706
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Generational variation and stabilization in resynthesized allotetraploid Brassica juncea derived from diploid progenitors B. rapa and B. nigra.

BMC plant biology·2026
Same author

Reconfigurable MIMO antenna for Sub-6 GHz 5G cognitive radio with machine learning based metaheuristic optimization.

Scientific reports·2026
Same author

The Influence of Gut Microbiome on Alpha-Synuclein Aggregation: Implications for Parkinson's Disease Pathogenesis.

Molecular neurobiology·2026
Same author

Waste water remediation through ultrafast reduction of organic dyes, nitroaromatics, and nitrofuran antibiotics employing efficient multifunctional rGO/Ni-MOF composites.

RSC advances·2026
Same author

Structure-based virtual screening and molecular dynamics elucidate novel inhibitors of HIV-1 TAR RNA from enamine library.

Scientific reports·2026
Same author

Triple-enzyme mimetic hemocompatible nanoparticles for glioblastoma targetingviapH-responsive enhanced ROS generation.

Colloids and surfaces. B, Biointerfaces·2026

相关实验视频

Updated: Sep 18, 2025

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.7K

通过纳米技术驱动的智能系统彻底改变糖尿病管理.

Aayush Kaushal1, Aanchal Musafir1, Gourav Sharma1

  • 1University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India.

Pharmaceutics
|June 27, 2025
PubMed
概括

纳米技术和人工智能 (AI) 正在彻底改变糖尿病管理. 这些创新提供了改善的胰岛素输送,持续的葡萄糖监测和个性化治疗,提高了患者的治疗结果和生活质量.

关键词:
在糖尿病管理中的AI.碳纳米材料的碳纳米材料持续的葡萄糖监测 (CGM)在糖尿病中,糖尿病是血糖性糖尿病.糖尿病患者的伤口愈合药物输送系统是药物输送系统.电化学生物传感器葡萄糖生物传感器葡萄糖监测是为了监测葡萄糖的水平.提供胰岛素的胰岛素输送.微针是一种微针.这些纳米纤维是纳米纤维.纳米医药是一种纳米医药.纳米技术是纳米技术.进行非侵入性监测.聚合物纳米粒子的聚合物纳米粒子.量子点 (QD) 是指一个量子点.智能纳米载体 智能纳米载体可穿戴生物传感器

更多相关视频

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.1K

相关实验视频

Last Updated: Sep 18, 2025

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.7K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
08:04

Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol

Published on: November 3, 2023

2.1K

科学领域:

  • 生物医学工程 生物医学工程
  • 材料科学 材料科学 材料科学
  • 内分泌学 在内分泌学.

背景情况:

  • 糖尿病是一种严重的全球健康负担,目前治疗疗效和长期控制的局限性.
  • 传统的糖尿病管理策略往往难以实现最佳的血糖控制和预防并发症.
  • 纳米技术为改善药物输送,葡萄糖监测和糖尿病护理中的治疗精度提供了新的解决方案.

研究的目的:

  • 审查纳米技术在重塑糖尿病诊断和治疗方面的当前进展和未来潜力.
  • 探索人工智能 (AI) 与纳米技术的整合,以实现个性化的糖尿病管理.
  • 突出这些技术对改善患者生活质量的变革性影响.

主要方法:

  • 关于纳米技术在糖尿病管理中的应用,包括用于胰岛素输送的纳米系统和用于血糖监测的纳米传感器的当前文献的审查.
  • 探索使用纳米材料的向药物递送系统,如微针,碳纳米材料和量子点等.
  • 讨论人工智能 (AI) 在分析患者数据以进行个性化治疗调整和预测分析方面的协同作用.

主要成果:

  • 纳米技术导致了用于增强胰岛素输送的智能纳米系统和用于实时血糖监测的革命性纳米传感器.
  • 使用纳米材料的向药物递送系统可以提高治疗效率并最大限度地减少副作用.
  • 人工智能与纳米技术的整合使得糖尿病管理的个性化,数据驱动的治疗计划成为可能.

结论:

  • 纳米技术,特别是与人工智能相结合时,为糖尿病护理提供了一个变革性的方法,解决了传统方法的局限性.
  • 对纳米材料的安全性和生物相容性的持续研究对于临床转化至关重要.
  • 纳米技术和人工智能的融合承诺个性化,响应性和更有效的糖尿病管理策略的未来,显著改善患者的治疗结果.